GEN Exclusives

More »

GEN News Highlights

More »
Jan 17, 2012

Evotec, Harvard, and Brigham & Women’s Partner on Kidney Diseases

  • Evotec signed a collaboration with Harvard University and Brigham and Women’s Hospital focused on the discovery and development of biomarkers and treatments for kidney disease. Evotec and Harvard University are already partnering on a beta cell regeneration alliance, CureBeta, which they initiated in March 2011.

    The new CureNephron project, which brings in Brigham and Women’s Hospital scientists, will combine expertise in kidney biology, physiology, and disease, with tools to identify, validate, and develop new drug candidates and biomarkers. The work will focus particularly on identifying disease-modifying mechanisms involved in kidney diseases. Evotec claims the multidisciplinary efforts will provide both new insights into kidney disease biology, and lead to a pipeline of commercially viable drug candidates for both acute and chronic disease.

    “The primary mechanisms leading and driving the development of kidney damage have not been systematically explored,” says Harvard University’s Andy McMahon, M.D. “We aim to comprehensively screen for these mechanisms looking at how individual kidney cell types respond to acute and chronic insults during various stages of disease progression as well as during the recovery process.” 


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?